While we have demonstrated with the use of LCMV-specific peptides the antigen-specific responses in viral infection, future work would benefit from the use of CD8 tetramers or adoptive transfer of TCR transgenic T cells to further evaluate the effect of LCMV infection on antigen specific T cells in vivo. Here, CD8A is linked to viral infectious disease.